U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07213141) titled 'Incidence of Graves' Disease After COVID-19 Vaccination' on May 19.
Brief Summary: It is well known that an infection can be a triggering factor for the development of autoimmune thyroid disease. The COVID-19 pandemic was an example of this, with several reports of both subacute thyroiditis as well as Graves' disease occurring after experiencing SARS-CoV-2 disease. There have also been cases of Graves' disease reported after COVID-19 vaccination administration (<4 weeks between the vaccine and the development of hyperthyroidism). However, the current evidence is of low quality and consists mainly of case reports. A search strategy on...